Deficits in Spermatogenesis but not Neurogenesis are Alleviated by Chronic Testosterone Therapy in R6/1 Huntington's Disease Mice

Journal of Neuroendocrinology

Volumn 24, Issue 2, 2012, Pages 341-356

  Hannan, A J ^a   Ransome, M I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognition; Huntington's disease; Neurogenesis; Spermatogenesis; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; HUNTINGTIN; SODIUM CHLORIDE; TESTOSTERONE; TESTOSTERONE CIPIONATE;

ANDROGEN THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIOCHEMISTRY; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EXON; GENE OVEREXPRESSION; GENE REPLICATION; GENOTYPE; HIPPOCAMPUS; HUNTINGTON CHOREA; LOCOMOTION; LONG TERM CARE; MALE; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; ROTAROD TEST; SPERMATOGENESIS; TESTIS; TESTIS ATROPHY; TESTOSTERONE BLOOD LEVEL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; HUMANS; HUNTINGTON DISEASE; INFERTILITY, MALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGENESIS; NUCLEAR PROTEINS; SPERMATOGENESIS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84855938043     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02238.x     Document Type: Article

References (59)

1. Bates GP, Harper PS, Jones L. Huntington's Disease. 3rd edn. Oxford: Oxford University Press, 2002.
2. Walker FO. Huntington's disease. Lancet 2007; 369: 218-228.
3. HDCRG HsDCRG. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-983.
4. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trotter Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
5. Sipione S, Cattaneo E. Modeling Huntington's disease in cells, flies, and mice. Mol Neurobiol 2001; 23: 21-51.
6. Borrell-Pages M, Zala D, Humbert S, Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 2006; 63: 2642-2660.
7. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003; 60: 1615-1620.
8. van der Burg JM, Bjorkqvist M, Brundin P. Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 2009; 8: 765-774.
9. Abdipranoto A, Wu S, Stayte S, Vissel B. The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development. CNS Neurol Disord Drug Targets 2008; 7: 187-210.
10. Balu DT, Lucki I. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci Biobehav Rev 2009; 33: 232-252.
11. Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Bartlett PF, Hannan AJ. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci 2005; 22: 2081-2088.
12. Petersen A, Bjorkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 2006; 24: 961-967.
13. Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolie E, Morin F, Bachoud-Levi AC, Maison P. Neuroendocrine disturbances in Huntington's disease. PLoS ONE 2009; 4: e4962.
14. Robbins AO, Ho AK, Barker RA. Weight changes in Huntington's disease. Eur J Neurol 2006; 13: e7.
15. Stoy N, McKay E. Weight loss in Huntington's disease. Ann Neurol 2000; 48: 130-131.
16. Markianos M, Panas M, Kalfakis N, Vassilopoulos D. Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia. Ann Neurol 2005; 57: 520-525.
17. Van Raamsdonk JM, Murphy Z, Selva DM, Hamidizadeh R, Pearson J, Petersen A, Bjorkqvist M, Muir C, Mackenzie IR, Hammond GL, Vogl AW, Hayden MR, Leavitt BR. Testicular degeneration in Huntington disease. Neurobiol Dis 2007; 26: 512-520.
18. Galea LA. Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res Rev 2008; 57: 332-341.
19. Cheng CY, Mruk DD. A local autocrine axis in the testes that regulates spermatogenesis. Nat Rev Endocrinol 2010; 6: 380-395.
20. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev 1987; 8: 1-28.
21. Spritzer MD, Galea LA. Testosterone and dihydrotestosterone, but not estradiol, enhance survival of new hippocampal neurons in adult male rats. Dev Neurobiol 2007; 67: 1321-1333.
22. Papalexi E, Persson A, Bjorkqvist M, Petersen A, Woodman B, Bates GP, Sundler F, Mulder H, Brundin P, Popovic N. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease. Eur J Neurosci 2005; 22: 1541-1546.
23. Gil JM, Rego AC. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease. Brain Res Rev 2009; 59: 410-431.
24. Dellu F, Contarino A, Simon H, Koob GF, Gold LH. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 2000; 73: 31-48.
25. Ransome MI, Turnley AM. Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis. J Neurochem 2007; 102: 1953-1965.
26. Ransome MI, Turnley AM. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models. Hippocampus 2008; 18: 1034-1050.
27. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego, CA: Academic Press, 2001.
28. Li H, Wyman T, Yu ZX, Li SH, Li XJ. Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet 2003; 12: 2021-2030.
29. Ransome MI, Turnley AM. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2. Neuroscience 2005; 132: 673-687.
30. Winnall WR, Muir JA, Liew S, Hirst JJ, Meachem SJ, Hedger MP. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats. Int J Androl 2009; 32: 542-555.
31. Nithianantharajah J, Barkus C, Murphy M, Hannan AJ. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis 2008; 29: 490-504.
32. Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 2002; 115: 97-105.
33. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537-548.
34. Yanase T, Fan W. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma. Vitam Horm 2009; 80: 649-666.
35. Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2002; 2: 831-837.
36. Steger K, Aleithe I, Behre H, Bergmann M. The proliferation of spermatogonia in normal and pathological human seminiferous epithelium: an immunohistochemical study using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen. Mol Hum Reprod 1998; 4: 227-233.
37. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC. Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 2010; 42: 813-827.
38. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab 1993; 77: 776-779.
39. Rosenfeld RG, Hintz RL. Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration. Endocrinology 1980; 107: 1841-1848.
40. Phillip M, Palese T, Hernandez ER, Roberts CT Jr, LeRoith D, Kowarski AA. Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat. Endocrinology 1992; 130: 2865-2870.
41. Galea LA, Uban KA, Epp JR, Brummelte S, Barha CK, Wilson WL, Lieblich SE, Pawluski JL. Endocrine regulation of cognition and neuroplasticity: our pursuit to unveil the complex interaction between hormones, the brain, and behaviour. Can J Exp Psychol 2008; 62: 247-260.
42. Kohl Z, Kandasamy M, Winner B, Aigner R, Gross C, Couillard-Despres S, Bogdahn U, Aigner L, Winkler J. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease. Brain Res 2007; 1155: 24-33.
43. Naver B, Stub C, Moller M, Fenger K, Hansen AK, Hasholt L, Sorensen SA. Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse. Neuroscience 2003; 122: 1049-1057.
44. Martinez-Sanchis S, Aragon CM, Salvador A. Cocaine-induced locomotor activity is enhanced by exogenous testosterone. Physiol Behav 2002; 76: 605-609.
45. Long SF, Dennis LA, Russell RK, Benson KA, Wilson MC. Testosterone implantation reduces the motor effects of cocaine. Behav Pharmacol 1994; 5: 103-106.
46. Kindlundh AM, Lindblom J, Bergstrom L, Wikberg JE, Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur J Neurosci 2001; 13: 291-296.
47. Kindlundh AM, Lindblom J, Nyberg F. Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain. Brain Res 2003; 979: 37-42.
48. Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. J Neurochem 2005; 93: 1057-1068.
49. Weeks RA, Piccini P, Harding AE, Brooks DJ. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 1996; 40: 49-54.
50. Ulubaev A, Lee DM, Purandare N, Pendleton N, Wu FC. Activational effects of sex hormones on cognition in men. Clin Endocrinol (Oxf) 2009; 71: 607-623.
51. Oberlander JG, Schlinger BA, Clayton NS, Saldanha CJ. Neural aromatization accelerates the acquisition of spatial memory via an influence on the songbird hippocampus. Horm Behav 2004; 45: 250-258.
52. Matthiesson KL, McLachlan RI. Male hormonal contraception: concept proven, product in sight? Hum Reprod Update 2006; 12: 463-482.
53. Phillips BT, Gassei K, Orwig KE. Spermatogonial stem cell regulation and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365: 1663-1678.
54. McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002; 57: 149-179.
55. Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley WF Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001; 86: 53-58.
56. O'Donnell L, McLachlan RI, Wreford NG, de Kretser DM, Robertson DM. Testosterone withdrawal promotes stage-specific detachment of round spermatids from the rat seminiferous epithelium. Biol Reprod 1996; 55: 895-901.
57. O'Donnell L, McLachlan RI, Wreford NG, Robertson DM. Testosterone promotes the conversion of round spermatids between stages VII and VIII of the rat spermatogenic cycle. Endocrinology 1994; 135: 2608-2614.
58. Hermann BP, Sukhwani M, Hansel MC, Orwig KE. Spermatogonial stem cells in higher primates: are there differences from those in rodents? Reproduction 2010; 139: 479-493.
59. Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol 2008; 20: 705-712.